Social inequalities in lung cancer screening in China: a cross-sectional study

Background: Lung cancer is the leading cause of cancer-related deaths in China, while screening for lung cancers offers an opportunity for early detection and reduced mortality. Limited data exist on nationwide lung cancer screening uptake in China, particularly concerning social inequalities. This study aims to assess lung cancer screening uptake situation in China, examine sociodemographic factors associated with screening participation, and identify barriers to screening, particularly in relation to social inequalities. Methods: Between September 2022 and January 2023, we conducted the Chinese Residents Cancer Screening Services Survey, assessing uptake and willingness to participate in screening for various cancers, including lung cancer. The survey included a nationally representative sample of 10,000 adults aged 35-69 from 100 counties and districts across 26 provinces. Lung cancer screening uptake was defined as prior participation in chest or lung CT scans for cancer screening or detection. Key variables examined include age, gender, smoking habits, and individual-level and area-level socioeconomic status. Findings: Lifetime lung cancer screening rates were 37.21% (95% CI 35.83-38.61) for men and 39.58% (95% CI 38.26-40.92) for women, while screening within the past five years was 34.42% (95% CI 33.07-35.80) for men and 37.47% (95% CI 36.16-38.80) for women. Smokers had the lowest uptake (33.97%, 95% CI 32.12-35.86) compared to ever-smokers (46.77%, 95% CI 43.05-50.51) and never-smokers (39.25%, 95% CI 38.08-40.42). Rural residents had lower uptake (26.59%, 95%CI 25.03-28.20) compared to urban residents (43.67%, 95%CI 42.50-44.84). Education and income levels were strongly associated with screening participation, with higher rates in richer and educated individuals. Area-level social inequalities were also notable, with screening uptake ranging from 56.87% (95% CI 54.32-59.39) in the least deprived 10% counties to 26.00% (95% CI 22.21-30.08) in the most deprived 10%. Across all socioeconomic groups, the primary reason for not participating in cancer screening was the belief that their risk of cancer was too low, while socially vulnerable groups were more likely to be deterred by screening costs or fear of a cancer diagnosis. Interpretation: Lung cancer screening uptake in China remains low, particularly among smokers. Notable social inequalities in screening participation were identified, with lower uptake among rural residents and individuals with socioeconomic disadvantages at both the individual and area levels. Targeted public health interventions are crucial to raise awareness and improve access to lung cancer screening, especially in underserved communities. Funding: China Development Research Foundation.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Western Pacific
Published
2025-02-01
DOI
https://doi.org/10.1016/j.lanwpc.2024.101317
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Social inequalities in lung cancer screening in China: a cross-sectional study

Lu Chang, Jiantuo Yu, Zixuan Yang, Qianyi Xia et al.
The Lancet Regional Health - Western Pacific
Global Cancer Incidence and Screening
article

Social inequalities in lung cancer screening in China: a cross-sectional study

Lu Chang, Jiantuo Yu, Zixuan Yang, Qianyi Xia, Zhicheng Wang, Haomin Yang, Pengyun Meng
article en

Abstract

Background: Lung cancer is the leading cause of cancer-related deaths in China, while screening for lung cancers offers an opportunity for early detection and reduced mortality. Limited data exist on nationwide lung cancer screening uptake in China, particularly concerning social inequalities. This study aims to assess lung cancer screening uptake situation in China, examine sociodemographic factors associated with screening participation, and identify barriers to screening, particularly in relation to social inequalities. Methods: Between September 2022 and January 2023, we conducted the Chinese Residents Cancer Screening Services Survey, assessing uptake and willingness to participate in screening for various cancers, including lung cancer. The survey included a nationally representative sample of 10,000 adults aged 35-69 from 100 counties and districts across 26 provinces. Lung cancer screening uptake was defined as prior participation in chest or lung CT scans for cancer screening or detection. Key variables examined include age, gender, smoking habits, and individual-level and area-level socioeconomic status. Findings: Lifetime lung cancer screening rates were 37.21% (95% CI 35.83-38.61) for men and 39.58% (95% CI 38.26-40.92) for women, while screening within the past five years was 34.42% (95% CI 33.07-35.80) for men and 37.47% (95% CI 36.16-38.80) for women. Smokers had the lowest uptake (33.97%, 95% CI 32.12-35.86) compared to ever-smokers (46.77%, 95% CI 43.05-50.51) and never-smokers (39.25%, 95% CI 38.08-40.42). Rural residents had lower uptake (26.59%, 95%CI 25.03-28.20) compared to urban residents (43.67%, 95%CI 42.50-44.84). Education and income levels were strongly associated with screening participation, with higher rates in richer and educated individuals. Area-level social inequalities were also notable, with screening uptake ranging from 56.87% (95% CI 54.32-59.39) in the least deprived 10% counties to 26.00% (95% CI 22.21-30.08) in the most deprived 10%. Across all socioeconomic groups, the primary reason for not participating in cancer screening was the belief that their risk of cancer was too low, while socially vulnerable groups were more likely to be deterred by screening costs or fear of a cancer diagnosis. Interpretation: Lung cancer screening uptake in China remains low, particularly among smokers. Notable social inequalities in screening participation were identified, with lower uptake among rural residents and individuals with socioeconomic disadvantages at both the individual and area levels. Targeted public health interventions are crucial to raise awareness and improve access to lung cancer screening, especially in underserved communities. Funding: China Development Research Foundation.

The Lancet Regional Health - Western PacificVol. 55
Fujian Medical University (CN), University Medical Center Groningen (NL), Harvard University (US), University of Groningen (NL), Karolinska Institutet (SE), China Development Bank (CN)
Reduced inequalities
Openalex Percentile: Top 96%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.